Home » Topics » Regulatory

Regulatory
RSS

Abilify sNDA submitted for long-term treatment of schizophrenia

Feb. 27, 2003

Approval sought for once-daily Reminyl

Feb. 27, 2003

Label for Botox widened in Europe

Feb. 27, 2003

Viread recommended for approval in E.U. for use in treatment-naive HIV patients

Feb. 26, 2003

CPMP recommends approval of Remicade for ankylosing spondylitis, label expansion

Feb. 26, 2003

Metformin XT NDA accepted for filing by FDA

Feb. 24, 2003

Eligard 30 mg receives FDA approval

Feb. 20, 2003

Approvable letter issued for Zelapar

Feb. 20, 2003

Effexor XR approved for social anxiety disorder

Feb. 14, 2003

Bayer seeks expansion of aspirin labeling to include prevention of first heart attack

Feb. 14, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...
Gensci-134: a long-acting growth hormone receptor agonist fusion protein
BioWorld Science
Gensci-134 (Genescience Pharmaceuticals Co. Ltd.) is a growth hormone receptor (GHR) agonist fusion protein that mimics the biological activity of growth hormone...